Composition with auxiliary blood sugar reduction efficacy, and preparation method and application thereof

Abstract

The invention provides a composition with an auxiliary blood sugar reduction efficacy, and a preparation method and application thereof, and relates to the technical field of medical care. The composition is mainly prepared from the raw materials in parts by weight: 20 to 50 parts of L-arabinose and a bitter gourd preparation, wherein the bitter gourd preparation comprises any one material of 15 to 35 parts of bitter gourd powder, 10 to 50 parts of bitter gourd extracts and 1 to 5 parts of bitter gourd polypeptide. The composition has the advantages that on one hand, the effects of controlling the conversion and adsorption of the human body on sugar and enhancing the insulin are achieved, and the blood sugar can be reduced in a synergistic way; and on the other hand, the recipe selects raw materials with simple ingredients, so that the absorption is easy, and the dependence cannot be easily generated. The preparation method of the composition is characterized in that the raw materials and a bonding agent are mixed and are prepared into granules. The preparation method has the advantages that the technological process is short; the operability is high; and the industrial production is facilitated.

Description

technical field [0001] The invention relates to the field of medical care, and in particular to a composition with the effect of assisting in lowering blood sugar, a preparation method and application thereof. Background technique [0002] Diabetes is a chronic disease responsible for approximately 1.5 million deaths in 2012 as a direct result of the disease, with more than 80% of these deaths occurring in low- and middle-income countries. According to WHO forecasts, by 2030, diabetes will become the seventh leading cause of death. There are two main forms of diabetes. People with type 1 diabetes usually cannot secrete their own insulin and therefore require insulin injections to stay alive. Type 2 diabetes, which accounts for about 90 percent of all diabetes cases, usually produces its own insulin, but doesn't produce enough or use it properly. [0003] At present, my country's hypoglycemic market is dominated by synthetic drugs, accounting for about 73.68% of the entire...

AI Technical Summary

Problems solved by technology

Type 2 diabetes, which accounts for about 90 percent of all diabetes cases, often produces its own insulin, but does not produce enough or use it properly

[0003] At present, my country's hypoglycemic market is dominated by synthetic drugs, accounting for about 73.68% of the entire market share; however, long-term use of synthetic drugs is likely to cause drug resistance, drug resistance, liver and kidney damage, etc.

And in about 26% of the natural medicine market, most of the selected natural medicine formulations are not reasonable enough and cannot lower blood sugar in multiple ways

Images